 | Adverum Biotechnologies, Inc. | |||
| NCM : ADVM || Location: United States | ||||
$9.49-0.7 (-6.87%) |
0.74 M | 9.35 - 10.22 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.131 M |
| March 28, 2024 | 0.890 M |
| March 15, 2024 | 0.648 M |
| Feb. 29, 2024 | 5.426 M |
| Feb. 15, 2024 | 4.009 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -3.43 | -2.30 | 33.02% |
| 09/30/2023 | -3.21 | -3.30 | -2.65% |
| 06/30/2023 | -3.35 | -3.10 | 7.57% |
| 03/31/2023 | -0.33 | -0.29 | 11.26% |
| 12/31/2022 | -0.37 | -0.33 | 10.71% |
ADVM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 20.755M | Shares Float | 11.719M |
| Short Float | 1.131M | Market Cap | 211.49M |
| Institution ownership | 83.53% | Insider ownership | 0.909% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -11.60 | Forward EPS | -5.43 |